About this trial
The aim of this study is to assess weight gain of preterm infants (gestational age lower than 32 weeks) fed infant milk formula with about 60% beta-palmitate (EX\_IMF) vs infant milk formula with similar macronutrient, mineral and fatty acid composition but lower amounts of beta-palmitate (ST\_IMF). Own mother milk (OMM) fed infants will serve as reference group.
Eligibility criteria
Qualifiers
gestational age between 24 and 32 weeks of gestation at enrollment,
birth weight greater than 750 grams,
singleton or twin birth (no triplet or higher),
fraction of inspired oxygen lower than 0.60 at enrollment,
Disqualifiers
congenital malformations, genetic, metabolic and endocrine disorders,
suspicious infection at enrollment,
intrauterine growth restriction (<10th centile) at enrollment,
maternal diabetes requiring insulin therapy,
Trial design
Treatments tested in this trial
- EX_IMF
- ST_IMF
Treatment groups
Sponsors and collaborators
Ospedali Riuniti Ancona
Lead sponsor
Istituto di Ricerca Pediatrica Città della Speranza
Collaborator
Bunge Loders Croklaan
Collaborator